Publications:  Dr Md Pranjol

Pranjol MZI, Zinovkin DA, Maskell ART, Stephens LJ, Achinovich SL, Los' DM, Nadyrov EA, Hannemann M et al.(2019). Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma. J Transl Med vol. 17, (1)

Przystal JM, Waramit S, Pranjol MZI, Yan W, Chu G, Chongchai A, Samarth G, Olaciregui NG et al.(2019). Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma. EMBO Mol Med vol. 11, (4)

PRANJOL MZI, Tabish TA(2019). Graphene Oxide-Based Targeting of Extracellular Cathepsin D and Cathepsin L As A Novel Anti-Metastatic Enzyme Cancer Therapy. Cancers vol. 11, (3) Article 319,

Pranjol MZI, Gutowski NJ, Hannemann M, Whatmore JL(2019). Cathepsin L induces proangiogenic changes in human omental microvascular endothelial cells via activation of the ERK1/2 pathway. Curr Cancer Drug Targets

Zinovkin DA, Pranjol MZI, Kravchenko D, Kravchenko O, Kudryashov V(2018). Gaucher Disease Involving Virchow's Lymph Node: a Case Report. Folia Med (Plovdiv) vol. 60, (4) 647-650.

Zinovkin DA, Pranjol MZI, Bilsky IA, Zmushko VA(2018). Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes. Cancer Microenviron vol. 11, (2-3) 107-114.

Tabish TA, Pranjol MZI, Jabeen F, Abdullah T, Latif A, Khalid A, Ali M, Hayat H et al.(2018). Investigation into the toxic effects of graphene nanopores on lung cancer cells and biological tissues. Applied Materials Today vol. 12, 389-401.

Pranjol MZI, Gutowski NJ, Hannemann M, Whatmore JL(2018). Cathepsin D non-proteolytically induces proliferation and migration in human omental microvascular endothelial cells via activation of the ERK1/2 and PI3K/AKT pathways. Biochim Biophys Acta Mol Cell Res vol. 1865, (1) 25-33.

Tabish TA, Pranjol MZI, Karadag I, Horsell DW, Whatmore JL, Zhang S(2018). Influence of luminescent graphene quantum dots on trypsin activity. Int J Nanomedicine vol. 13, 1525-1538.

Russell H, Pranjol MZI(2018). Transcription factors controlling E-cadherin downregulation in ovarian cancer. Bioscience Horizons vol. 11,

Tabish TA, Pranjol MZI, Hayat H, Rahat AAM, Abdullah TM, Whatmore JL, Zhang S(2017). In vitro toxic effects of reduced graphene oxide nanosheets on lung cancer cells. Nanotechnology vol. 28, (50)

Zinovkin DA, Pranjol MZI, Petrenyov DR, Nadyrov EA, Savchenko OG(2017). The Potential Roles of MELF-Pattern, Microvessel Density, and VEGF Expression in Survival of Patients with Endometrioid Endometrial Carcinoma: A Morphometrical and Immunohistochemical Analysis of 100 Cases. J Pathol Transl Med vol. 51, (5) 456-462.

Zinovkin D, Pranjol MZI(2016). Tumor-Infiltrated Lymphocytes, Macrophages, and Dendritic Cells in Endometrioid Adenocarcinoma of Corpus Uteri as Potential Prognostic Factors: An Immunohistochemical Study. Int J Gynecol Cancer vol. 26, (7) 1207-1212.

Pranjol MZI, Gutowski N, Hannemann M, Whatmore J(2015). The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer. Biomolecules vol. 5, (4) 3260-3279.

Pranjol MZI, Hajitou A(2015). Bacteriophage-derived vectors for targeted cancer gene therapy. Viruses vol. 7, (1) 268-284.